Because previous reports have indicated that Treg populations can be increased in circulating lymphocytes from cancer patients as compared to healthy individuals, we compared the proportion of CD4+ T-cell subsets in circulating lymphocytes of EOC patients to healthy donors. This evidence concerns the gene CD4 and cancer.